(Q40309976)

19 September 2017

Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients (English)

1 reference

19 September 2017

phase I clinical trial

0 references

1 reference

1 reference

Hisahito Endo

1

1 reference

19 September 2017

Takuro Saito

2

1 reference

19 September 2017

Akira Kenjo

3

1 reference

19 September 2017

Mika Hoshino

4

1 reference

19 September 2017

Masanori Terashima

5

1 reference

19 September 2017

Tetsu Sato

6

1 reference

19 September 2017

Takayuki Anazawa

7

1 reference

19 September 2017

Takashi Kimura

8

1 reference

19 September 2017

Takao Tsuchiya

9

1 reference

19 September 2017

Atsushi Irisawa

10

1 reference

19 September 2017

Hiromasa Ohira

11

1 reference

19 September 2017

Takuto Hikichi

12

1 reference

19 September 2017

Tadayuki Takagi

13

1 reference

19 September 2017

Mitsukazu Gotoh

14

1 reference

19 September 2017

1 July 2012

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

19 September 2017

1 reference

19 September 2017

19

1 reference

19 September 2017

4

1 reference

19 September 2017

465-475

1 reference

https://scigraph.springernature.com/pub.10.1007/s00534-011-0457-7

19 September 2017

0 references

cites work

The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

EUS-guided photodynamic therapy of the pancreas: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

EUS-guided ethanol injection of normal porcine pancreas: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0457-7

10.1007/S00534-011-0457-7

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference